Results for tag: "Anacetrapib"

Anacetrapib is a drug used in the treatment of cardiovascular diseases. It is a cholesteryl ester transfer protein (CETP) inhibitor, which works by blocking the transfer of cholesterol from HDL (high-density lipoprotein) to LDL (low-density lipoprotein). This helps to reduce the risk of cardiovascular events such as heart attack and stroke. Anacetrapib is used in combination with other drugs such as statins, fibrates, and niacin to reduce cholesterol levels. It is also used to reduce the risk of cardiovascular events in patients with established cardiovascular disease. Anacetrapib is a relatively new drug, and is still in the early stages of development. It is currently being studied in clinical trials to assess its safety and efficacy. The results of these trials will determine whether it will be approved for use in the treatment of cardiovascular diseases. Several pharmaceutical companies are involved in the development of Anacetrapib, including Merck, Pfizer, and Eli Lilly. These companies are researching the drug in order to bring it to market and make it available to patients. Show Less Read more